Verona Pharma plc

Ownership Transactions Reported by 19 Insiders

Symbol
VRNA on Nasdaq
Industry
Pharmaceutical Preparations
Location
3 More London Riverside, London, United Kingdom

Insiders trading volume in the past year

Verona Pharma plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Access Industries Holdings LLC 10%+ Owner $110M Aug 15, 2022
Orbimed Advisors Llc Director $7.46M May 11, 2023
Rishi Gupta Director $7.46M May 11, 2023
Claire Poll General Counsel $5.53M Feb 1, 2024
Lisa Deschamps Director $0 Oct 7, 2025
James Aloysius Brady Director $0 Oct 7, 2025
Kenneth Cunningham Director $0 Oct 7, 2025
Anders Ullman Director $0 Oct 7, 2025
Martin Edwards Director $0 Oct 7, 2025
Andrew Fisher General Counsel $0 -$1.16M -100% Oct 7, 2025
Kathleen A. Rickard Chief Medical Officer $0 -$3.6M -100% Oct 7, 2025
Mark W. Hahn Chief Financial Officer $0 -$19.4M -100% Oct 7, 2025
David Zaccardelli President and CEO, Director $0 -$19.4M -100% Oct 7, 2025
Michael Austwick Director $0 Oct 7, 2025
Mahendra Shah Director $0 Oct 7, 2025
David R. Ebsworth Director $0 Oct 7, 2025
Vikas Sinha Director $0 -$2.93M -100% Oct 7, 2025
Christina Ackermann Director $0 -$338K -100% Oct 7, 2025
Andrew Sinclair Director Aug 9, 2021

Recent Insider Transactions by Companies or Individuals for Verona Pharma plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.